Elecsys CSF AD immunoassays: Sample stability for a new pre‐analytical protocol for fresh CSF
Alzheimer's & Dementia · 2025
DOI: 10.1002/alz.70797 ↗Kurz gefasst
Studienprotokoll in der Zeitschrift Alzheimer's & Dementia, 2025. Verfasst von Ekaterina Manuilova und 6 weiteren Autor:innen. Beteiligte Einrichtung: Roche Diagnostics GmbH, Penzberg, Germany. Hauptthemen laut MEDLINE: Alzheimer Disease, Amyloid beta-Peptides, tau Proteins, Peptide Fragments. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Roche Diagnostics International Ltd, Rotkreuz, Switzerland.
Abstract (Originalsprache)
INTRODUCTION Amyloid beta 1–42 (Aβ42), tau phosphorylated at threonine‐181 (p‐tau181), and total tau (t‐tau) are cerebrospinal fluid (CSF) biomarkers for Alzheimer's disease diagnosis. METHODS We prospectively examined storage time, temperature, and freeze/thaw effects on Aβ42, p‐tau181, and t‐tau stability in fresh CSF samples using Elecsys ® CSF immunoassays. RESULTS All three biomarkers were stable at 2–8°C for ≤15 days, and −25°C to −15°C for ≤8 weeks, and after one freeze/thaw cycle. p‐Tau181 and t‐tau were also stable at 15–25°C for ≤8 days and at −25°C to −15°C for 12–15 weeks. Aβ42 recovery declined slightly after storage at 15–25°C for ≤8 days and −25°C to −15°C for 12–15 weeks, and one freeze/thaw cycle. DISCUSSION For optimal immunoassay performance, it is recommended to store CSF samples at 15–25°C for ≤5 days, 2–8°C for ≤15 days, and −25°C to −15°C for ≤8 weeks. Highlights Cerebrospinal fluid (CSF) biomarkers aid in Alzheimer's disease diagnosis. Fresh CSF stored at 15–25°C for ≤5 days is optimal for Elecsys CSF immunoassays. Fresh CSF stored at 2–8°C for ≤15 days is optimal for Elecsys CSF immunoassays. Fresh CSF stored at −25°C to −15°C for ≤8 weeks is optimal for Elecsys CSF immunoassays.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Roche Diagnostics GmbH, Penzberg, Germany.
- Roche Diagnostics International Ltd, Rotkreuz, Switzerland.
- Technical University of Munich (TUM), School of Medicine and Health, TUM University Hospital, Munich, Germany.
ORCID-Profile: Timo Grimmer
Förderung
- Roche Diagnostics International Ltd, Rotkreuz, Switzerland
Zitieren
APA
Manuilova, E., Schrurs, I., Rutz, S., McIlwrick, S., Goldhardt, O., Sommer, P., & Grimmer, T. (2025). Elecsys CSF AD immunoassays: Sample stability for a new pre‐analytical protocol for fresh CSF. Alzheimer's & Dementia. https://doi.org/10.1002/alz.70797
Vancouver
Manuilova E, Schrurs I, Rutz S, McIlwrick S, Goldhardt O, Sommer P, et al. Elecsys CSF AD immunoassays: Sample stability for a new pre‐analytical protocol for fresh CSF. Alzheimer's & Dementia. 2025. doi:10.1002/alz.70797
BibTeX
@article{Manuilova2025,
author = {Manuilova, Ekaterina and Schrurs, Isabelle and Rutz, Sandra and McIlwrick, Silja and Goldhardt, Oliver and Sommer, Patrick and Grimmer, Timo},
title = {Elecsys CSF AD immunoassays: Sample stability for a new pre‐analytical protocol for fresh CSF},
journal = {Alzheimer's & Dementia},
year = {2025},
doi = {10.1002/alz.70797}
}
EUVIMED